Order results by:
| Issue | Title | |
| Vol 13, No 1 (2017) | CHANGE OF ARRHYTHMIC EVENTS IN ACUTE MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION AFTER PHARMACOINVASIVE REVASCULARIZATION | Abstract similar documents |
| V. E. Oleynikov, E. A. Shigotarova, A. V. Kulyutsin, E. V. Dushina, J. A. Guskova | ||
| "... intervention (PCI), were included into the study. Telemetry ECG was performed before and after PCI ..." | ||
| Vol 16, No 3 (2020) | The Short-Term Effect of Stent Size and Number on Left Ventricular Systolic Function Improvement After Elective Percutaneous Coronary Intervention | Abstract PDF (Eng) similar documents |
| Sh. Mostafa, O. Sanad, M. Shawky, M. Magdy, E. Elkeshk | ||
| "... .94%. One month after PCI, mean GLPSS improved significantly to -14.05±1.72% (p<0.001), 3 months after PCI ..." | ||
| Vol 13, No 6 (2017) | HEART RATE VARIABILITY, VENTRICULAR LATE POTENTIALS AND HEART RATE TURBULENCE AS INDICATORS OF CORONARY REPERFUSION IN ST SEGMENT ELEVATION MYOCARDIAL INFARCTION | Abstract similar documents |
| E. A. Shigotarova, E. V. Dushina, V. A. Galimskaya, V. E. Oleynikov | ||
| "... criteria, followed by (3-24 hour later) coronary angiography with percutaneous coronary intervention (PCI ..." | ||
| Vol 9, No 6 (2013) | THROMBOLYSIS OR PRIMARY PCI FOR MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION? THE STREAM TRIAL (STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION) | Abstract similar documents |
| V. A. Sulimov | ||
| "... , coupled with timely coronary angiography, and primary percutaneous coronary intervention (PCI ..." | ||
| Vol 13, No 1 (2017) | EVALUATION OF TREATMENT OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION BEFORE REFERENCE EVENT AND BEFORE DISCHARGE FROM THE HOSPITAL: REGISTER DATA (KHABAROVSK CITY). PART 2 | Abstract similar documents |
| L. N. Malay, S. Yu. Martsevich, L. V. Solokhina, Y. M. Bukhonkina, K. E. Poshatayev, N. B. Garayeva, A. Ya. Letskin | ||
| "... with non-STEMI (p<0.001). In STEMI patients lethality was 3.3 times lower in PCI-positive patients ..." | ||
| Vol 16, No 2 (2020) | The Effect of Pharmacological Preconditioning with Nicorandil before Elective Coronary Stenting on the Long-Term Prognosis of Patients with Stable Coronary Artery Disease | Abstract similar documents |
| G. N. Soboleva, R. V. Gostishchev, A. N. Rogoza, T. I. Kotkina, A. N. Samko, Yu. A. Karpov | ||
| "... the next year after the PCI (p=0.01). In patients with type 4a MI CVE odd ratio increases 5.8 times ..." | ||
| Vol 17, No 3 (2021) | The Effect of Clinical Characteristics and Stent Parameters on Left Ventricular Mechanical Dyssynchrony | Abstract PDF (Eng) similar documents |
| S. Mostafa, O. Sanad, M. Shawky, M. Magdy, E. Elkeshk | ||
| "... after PCI TSI improved significantly to 163.7±17.6 ms (p<0.001), 3 months after PCI showed more ..." | ||
| Vol 12, No 5 (2016) | Clinical and Laboratory Predictors of Major Adverse Cardiac Events in Patients with Ischemic Heart Disease Following Elective Percutaneous Coronary Intervention | Abstract similar documents |
| E. Z. Golukhova, M. V. Grigoryan, M. N. Ryabinina, N. I. Bulaeva | ||
| "... pharmacological strategies, complications and adverse events following percutaneous coronary interventions (PCI ..." | ||
| Vol 17, No 2 (2021) | Comorbidities and Percutaneous Coronary Intervention in Elderly Patients with Acute Coronary Syndrome | Abstract PDF (Eng) similar documents |
| M. Yu. Gilyarov, E. V. Konstantinova, M. R. Atabegashvili, T. D. Solntseva, D. A. Anichkov, А. N. Kostina, R. V. Polybin, A. E. Udovichenko, A. V. Svet | ||
| "... . Percutaneous coronary intervention (PCI) was performed in 42% of patients. In patients with STEMI and NSTEMI ..." | ||
| Vol 13, No 4 (2017) | HIGH DOSES OF STATINS BEFORE PERCUTANEOUS CORONARY INTERVENTION: WHETHER THERE ARE REASONS TO USE? | Abstract similar documents |
| I. S. Yavelov, M. V. Zhatkina, O. M. Drapkina, A. Yu. Gorshkov, N. O. Myasnikova | ||
| "... statins in high doses before percutaneous coronary interventions (PCI) are presented in the review ..." | ||
| Vol 7, No 5 (2011) | HOMOCYSTEINE-LOWERING THERAPY AND LONG-TERM PROGNOSIS AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION | Abstract similar documents |
| O. O. Shakhmatova, A. L. Komarov, A. N. Samko, T. I. Kotkina, D. V. Rebrikov, A. D. Deev, E. P. Panchenko | ||
| "... to daily maintenance) on long-term prognosis after elective percutaneous coronary intervention (PCI ..." | ||
| Vol 14, No 4 (2018) | Hospital Stage of Myocardial Infarction Treatment in 13 Regions of Russian Federation by Results of the International Research | Abstract PDF (Eng) similar documents |
| A. V. Kontsevaya, K. Bates, E. A. Goryachkin, N. Bobrova, L. I. Syromiatnikova, Yu. V. Popova, D. Yu. Platonov, I. V. Osipova, A. M. Nedbaikin, T. N. Malorodova, O. A. Mirolyubova, D. V. Kryuchkov, L. A. Khaisheva, A. S. Galyavich, M. V. Franz, A. Yu. Efanov, D. V. Duplyakov, O. M. Drapkina, D. Leon, M. McKee | ||
| "... PCI, and 2.2% CABG. Turning to cardiovascular risk factors, 46.2% of patients smoked prior ..." | ||
| Vol 7, No 2 (2011) | COST-EFFECTIVENESS EVALUATION OF PREHOSPITAL THROMBOLYSIS WITH TENECTEPLASE | Abstract similar documents |
| V. V. Omel'yanovskiy, E. V. Derkach, P. M. Khaylov, S. N. Tereshchenko | ||
| "... on reperfusion strategy (no reperfusion, percutaneous coronary intervention (PCI), prehospital thrombolysis ..." | ||
| Vol 14, No 6 (2018) | P2Y12 Receptor Inhibitors in the Treatment of Patients with Acute Coronary Syndrome and Percutaneous Coronary Intervention: Possibilities of Prasugrel | Abstract PDF (Eng) similar documents |
| N. M. Vorobyeva | ||
| "... coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) are discussed in the article ..." | ||
| Vol 20, No 3 (2024) | Use of glycoprotein IIb/IIIa inhibitors in myocardial infarction in the Russian Federation, according to the Russian Registry of Acute Myocardial Infarction REGION-IM | Abstract similar documents |
| N. S. Kostritca, R. M. Rabinovich, R. M. Shakhnovich, I. S. Yavelov, R. G. Gulyan, Yu. K. Rytova, S. N. Tereschenko, A. D. Erlikh, D. V. Pevzner | ||
| "... (PCI), while among patients with non-ST elevation myocardial infarction, the frequency of IIb/IIIa ..." | ||
| Vol 18, No 6 (2022) | Acute Coronary Syndrome after Percutaneous Coronary Intervention: State of the Problem and Clinical Practice Data | Abstract similar documents |
| I. S. Egorova, N. N. Vezikova | ||
| "... intervention (PCI), as well as the clinical features of the disease and lipid spectrum parameters. Material ..." | ||
| Vol 15, No 1 (2019) | Atrial Tachyarrhythmias and Atrial Flutter: the Basics of Diagnostics and Modern Opportunities of Therapy | Abstract similar documents |
| Yu. A. Bunin, S. A. Miklishanskaya, E. A. Zolozova, V. V. Chigineva | ||
| "... тахикардию, которой, как правило, уделяют недостаточно внимания в отечественной литературе, синоатриальную ..." | ||
| Vol 8, No 1 (2012) | RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION | Abstract similar documents |
| V. A. Sulimov, E. V. Moroz | ||
| "... in percutaneous coronary intervention (PCI), to identify clinical risk factors of resistance development, to study ..." | ||
| Vol 18, No 6 (2022) | What is changing in the treatment of acute coronary syndrome in the Russian Federation? | Abstract similar documents |
| S. A. Boytsov, B. G. Alekyan, R. M. Shakhnovich, V. I. Ganyukov | ||
| "... coronary intervention (PCI) (by 9.6%) and in the general STEMI group (by 12.3%); significantly increased ..." | ||
| Vol 9, No 3 (2013) | IMPACT OF LOCUS 9P21.3 SINGLE NUCLEOTIDE POLYMORPHISMS ON CORONARY ATHEROSCLEROSIS SEVERITY AND LONG-TERM OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION IN PATIENT WITH MYOCARDIAL INFARCTION | Abstract similar documents |
| P. A. Shesternya, G. V. Matyushin, S. Yu. Nikulina, A. S. Sergeeva | ||
| "... ) and coronary atherosclerosis severity and long-term outcomes after percutaneous coronary intervention (PCI ..." | ||
| Vol 20, No 1 (2024) | Clinical factors associated with the no/slow-reflow phenomenon in patients with acute coronary syndrome | Abstract similar documents |
| E. V. Konstantinova, Yu. S. Ilin, A. A. Velikotskiy, N. A. Rakhimi, A. A. Bogdanova, A. V. Ploshchenkov | ||
| "... syndrome (ACS) undergoing primary percutaneous coronary intervention (PCI), and to study factors associated ..." | ||
| Vol 17, No 4 (2021) | Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention | Abstract similar documents |
| A. V. Panov | ||
| "... therapy of patients with AF undergoing percutaneous coronary intervention (PCI) requires that multiple ..." | ||
| Vol 8, No 3 (2012) | CARDIOPROTECTIVE EFFECT OF PHYSICAL REHABILITATION IN PATIENTS WITH ISCHEMIC-ORIGIN DIASTOLIC DYSFUNCTION AFTER PERCUTANEOUS CORONARY INTERVENTION | Abstract similar documents |
| N. P. Lyamina, A. N. Nosenko, I. B. Razborova, O. V. Orlikova, E. V. Kotel'nikova, E. S. Karpova | ||
| "... ) with left ventricle diastolic dysfunction (DD) who underwent percutaneous coronary intervention (PCI ..." | ||
| Vol 14, No 2 (2018) | WHAT ARE THE OPPORTUNITIES OF PRASUGREL IN THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME | Abstract similar documents |
| M. Yu. Gilyarov, Е. V. Konstantinova | ||
| "... be considered in patients with ACS with percutaneous coronary intervention (PCI). Prasugrel therapy ..." | ||
| Vol 12, No 1 (2016) | Characteristic features, treatment and hospital outcomes in patients with acute myocardial infarction: Khabarovsk Register data. Part I | Abstract similar documents |
| L. N. Malay, L. V. Solokhina, Y. M. Bukhonkina, K. E. Poshatayev, H. B. Garayev, A. Ya. Letskin | ||
| "... ) admitted to the hospital with a possibility of primary percutaneous coronary intervention (PCI), according ..." | ||
| Vol 17, No 2 (2021) | Post-COVID Syndrome and Tachycardia: Theoretical Base and Treatment Experience | Abstract similar documents |
| V. I. Podzolkov, A. E. Bragina, A. I. Tarzimanova, L. V. Vasil'eva, E. P. Batrakova, N. V. Lobova, E. E. Bykova, M. M. Khachuroeva | ||
| "... синдром постуральной ортостатической тахикардии (ПОТ). В статье представлены патогенетические механизмы ..." | ||
| Vol 15, No 2 (2019) | Ventricular Tachycardia Induced by Exercise Test as a Predictor of Coronary Artery Disease Development | Abstract similar documents |
| A. A. Tatarinova, E. A. Ryngach, T. V. Treshkur, D. V. Ryzhkova, O. N. Zhdanova, D. V. Svalov | ||
| "... тахикардией, индуцированной нагрузкой, но без ишемических изменений миокарда по результатам стресс-тестов, и ..." | ||
| Vol 18, No 2 (2022) | Postural Orthostatic Tachycardia Syndrome as a Manifestation of Post-COVID-19 Syndrome | Abstract similar documents |
| E. L. Trisvetova | ||
| "... альтернативным диагнозом. Постуральная ортостатическая тахикардия как проявление постковидного синдрома описана у ..." | ||
| Vol 19, No 1 (2023) | Acute Coronary Syndrome during the Pandemic New Coronavirus Infection | Abstract similar documents |
| O. M. Drapkina, A. Ya. Kravchenko, A. V. Budnevskiy, A. V. Kontsevaya, E. S. Ovsyannikov, E. S. Drobysheva | ||
| "... (PCI), during a pandemic is experiencing great difficulties due to the formation of time delays ..." | ||
| Vol 7, No 6 (2011) | CORONARY EMBOLISM WITH FRAGMENTED THROMBUS FROM THE LEFT VENTRICLE IN PATIENT WITH POSTINFARCTION ANEURYSM | Abstract similar documents |
| Yu. F. Salakhova, S. V. Gar'kina, T. V. Kislukhin, D. V. Duplyakov, V. S. Ivanov, E. R. Perunova, E. I. Bazhenova, S. E. Burnazyan, S. M. Khokhlunov | ||
| "... and thrombus in the LV aneurysm is considered in details. Successful percutaneous coronary intervention (PCI ..." | ||
| Vol 18, No 4 (2022) | Impact of the COVID-19 Pandemic on Myocardial Revascularization in Patients with Acute Coronary Syndrome in the Russian Federation | Abstract PDF (Eng) similar documents |
| B. G. Alekyan, S. A. Boytsov, V. I. Ganyukov, E. M. Manoshkina | ||
| "... .3%); significantly increased mortality both in the general group (by 48%) and during PCI in patients with NSTE-ACS ..." | ||
| Vol 19, No 3 (2023) | Ventricular tachycardia and myocardial infarction during antiarrhythmic therapy: a case report | Abstract similar documents |
| A. A. Gurbanova, K. G. Pereverzeva, S. S. Yakushin, I. V. Budanova | ||
| "... В статье анализируется случай развития желудочковой тахикардии и инфаркта миокарда (ИМ) 2 типа ..." | ||
| Vol 19, No 1 (2023) | A Case of Successful Medical Treatment of Ventricular Tachycardia in a Patient With Ischemic Heart Disease and Heart Failure | Abstract similar documents |
| E. A. Ryngach, A. A. Tatarinova, E. S. Zhabina, O. N. Zhdanova, T. V. Treshkur | ||
| "... тахикардии), могут существенно различаться. Поэтому характеристики желудочковых нарушений ритма необходимо ..." | ||
| Vol 17, No 6 (2021) | Panic Attacks in Patients with Supraventricular Tachycardia: Problems of Differential Diagnosis and Impact on Quality of Life | Abstract PDF (Eng) similar documents |
| D. A. Tsaregorodtsev, P. A. Shelukha, L. V. Romasenko, M. M. Beraya, A. V. Sokolov | ||
| "... наджелудочковой тахикардией (НЖТ) в зависимости от наличия или отсутствия панических атак (ПА) в сравнении с ..." | ||
| Vol 13, No 2 (2017) | TREATMENT CHARACTERISTICS OF ACUTE CORONARY SYNDROME IN ELDERLY PATIENTS: PRACTICE OF N.I. PIROGOV CITY CLINICAL HOSPITAL №1 | Abstract similar documents |
| M. Yu. Gilyarov, M. O. Zheltoukhova, E. V. Konstantinova, M. D. Muksinova, L. S. Muradova, A. P. Nesterov, A. E. Udovichenko | ||
| "... . The incidence of percutaneous coronary intervention (PCI) and coronary angiography (CAG) significantly increased ..." | ||
| Vol 14, No 1 (2018) | NFLUENCE OF CYP4F2*3 ON RESPONSE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME | Abstract similar documents |
| K. B. Mirzaev, O. D. Konova, E. A. Grishina, K. A. Ryzhikova, Zh. A. Sozaeva, D. A. Andreev, M. Y. Gilyarov, D. A. Sychev | ||
| "... coronary syndrome (ACS) who underwent percutaneous coronary intervention (PCI). Material and methods ..." | ||
| Vol 9, No 3 (2013) | CLINICAL SIGNIFICANCE OF DRUGINDUCED INTERVALS QT AND QTC PROLONGATION | Abstract similar documents |
| N. V. Furman, S. S. Shmatova | ||
| "... сердца — желудочковой тахикардии типа «пируэт» (torsade de pointes). Наряду с врождённым, существует и ..." | ||
| Vol 15, No 5 (2019) | Association of rs556621 Polymorphism with Development of Stroke in Patients with Cardiovascular Pathology | Abstract similar documents |
| S. Yu. Nikulina, V. A. Shulman, A. A. Chernova, S. V. Prokopenko, D. A. Nikulin, I. M. Platunova, S. S. Tretyakova, V. N. Maksimov, A. A. Gurazheva | ||
| "... , пароксизмальные наджелудочковые тахикардии, дислипидемию, атеросклероз брахиоцефальных артерий, нарушения системы ..." | ||
| Vol 20, No 1 (2024) | Acute myocardial infarction-like event in a young patient with biventricular arrhythmogenic cardiomyopathy | Abstract similar documents |
| Y. V. Stavtseva, E. A. Mershina, T. V. Lobzhanidze, E. I. Bazdireva, N. I. Khutsishvili, Zh. D. Kobalava | ||
| "... коронарный синдром на фоне эпизода желудочковой тахикардии (ЖТ). На основании клинической картины, повышения ..." | ||
| Vol 17, No 6 (2021) | Damage to the Cardiovascular System in Patients with SARS-CoV-2 Coronavirus Infection. Part 1: Predictors of the Development of an Unfavorable Prognosis | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, I. I. Shvedov, E. E. Bykova, A. A. Ivannikov, L. V. Vasilyeva | ||
| "... .018), increased the likelihood of mechanical ventilation use (OR 1.451, CI 1.168-1.803, p<0.001) and stay ..." | ||
| Vol 11, No 4 (2015) | INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION | Abstract PDF (Eng) similar documents |
| K. B. Mirzaev, R. E. Kazakov, V. V. Smirnov, D. A. Andreev, D. A. Sychev | ||
| "... intervention (PCI): 64 males and 17 females, mean age 63.9±10.9 years. CYP2C19 allelic variants were detected ..." | ||
| Vol 15, No 2 (2019) | Cardiorenal relationships in the focus of risks of atrial fibrillation in patients after acute ST-elevated myocardial infarction (observational program FAKEL) | Abstract similar documents |
| I. A. Zolotovskaya, I. L. Davydkin, D. V. Duplyakov, V. A. Kokorin | ||
| "... percutaneous coronary intervention (PCI). Material and methods. The study was conducted with the inclusion ..." | ||
| Vol 16, No 5 (2020) | Treatment of Patients with Acute Coronary Syndrome with ST Segment Elevation in Clinical Practice of the Republic of Karelia: the Results of 10-year Register | Abstract similar documents |
| I. S. Skopets, N. N. Vezikova, A. V. Malafeev, A. N. Malygin, V. A. Litvinova | ||
| "... of reperfusion interventions (83.5%) with a predominance of percutaneous coronary intervention (PCI; 76 ..." | ||
| Vol 6, No 5 (2010) | THE USE OF ATORVASTATIN FOR THE PREVENTION OF RECURRENT ATRIAL FIBRILLATION AFTER ELECTRICAL CARDIOVERSION IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| S. N. Tereshchenko, N. G. Chuich, A. L. Syrkin, D. A. Andreev, A. V. Kolchurina, V. P. Terentev, A. Yu. Borozinets | ||
| "... , respectively (p<0.001). Episodes of sinus tachycardia decreased on 52.3% (p<0.001) and 48,5% (p<0.01 ..." | ||
| Vol 7, No 5 (2011) | HIGH VERSUS STANDARD CLOPIDOGREL MAINTENANCE DOSE AFTER PERCUTANEOUS CORONARY INTERVENTION AND EFFECTS ON PLATELET INHIBITION, ENDOTHELIAL FUNCTION, AND INFLAMMATION. RESULTS OF THE ARMYDA-150 MG (ANTIPLATELET THERAPY FOR REDUCTION OF MYOCARDIAL DAMAGE DURING ANGIOPLASTY) RANDOMIZED STUDY | similar documents |
| G. Patti, D. Grieco, G. Dicuonzo, V. Pasceri, A. Nusca, G. Sciascio | ||
| "... чрескожное коронарное вмешательство (ЧКВ). Материал и методы. Через месяц после ЧКВ (Т-0) 50 больных были ..." | ||
| Vol 19, No 5 (2023) | Nephroprotective effect of atorvastatin at a dose of 80 mg in patients with ST-segment elevation myocardial infarction with an invasive treatment strategy | Abstract similar documents |
| A. D. Gavrilko, E. M. Mezhonov, S. V. Shalaev, D. V. Krasheninin | ||
| "... coronary angiography (CAG) and percutaneous coronary intervention (PCI) was 100 [90-200] ml, while ..." | ||
| Vol 7, No 6 (2011) | EFFICACY OF CORONARY STENTING AND BASIC PHARMACOTHERAPY IN ELDERLY AND SENILE PATIENTS: THE RESULTS OF LONG-TERM PROSPECTIVE FOLLOW-UP | Abstract similar documents |
| L. R. Mirzakhanova | ||
| "... in patients after PCI in comparison with these in patients received only standard pharmacotherapy. At the end ..." | ||
| Vol 15, No 2 (2019) | Long-Term Outcomes of Pharmacoinvasive Reperfusion Strategy Depending on the Choice of Thrombolytic Agent in ST-Segment Elevation Myocardial Infarction | Abstract similar documents |
| A. V. Khripun, A. A. Kastanayan, M. V. Malevannyi, Y. V. Kulikovskikh | ||
| "... number of ventricular extrasystoles (4.5 [0; 32.0] vs 34, 0 [2.25; 80.25], p=0.001) with more favorable ..." | ||
| Vol 17, No 3 (2021) | Comparative Characteristics of Beta-Blockers in Patients with Congenital Long QT Syndrome | Abstract similar documents |
| A. Yu. Proshlyakov, P. Sh. Chomakhidze, N. A. Novikova | ||
| "... , эпизодов тахикардии, нередко развивается устойчивая полиморфная желудочковая тахикардия. Риск внезапной ..." | ||
| Vol 8, No 2 (2012) | 1C-INDUCED ATRIAL FLUTTER IN A PATIENT WITH WPW SYNDROME: CASE REPORT AND REVIEW | Abstract similar documents |
| R. R. Mamatkazina, I. P. Kolos, S. E. Serdyuk, E. P. Mazygula, A. V. Sveshnikov | ||
| "... аллапинина развился пароксизм «широкой» тахикардии, расцененный как пароксизм мерцания/трепетания предсердий ..." | ||
| Vol 8, No 5 (2012) | TITERS OF ANTIBODIES TO Β1-ADRENOCEPTOR AND M2 CHOLINERGIC RECEPTORS IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS WITHOUT AN ORGANIC CARDIOVASCULAR DISEASE AND THEIR POSSIBLE CLINICAL SIGNIFICANCE | Abstract similar documents |
| M. M. Rogova, N. A. Mironova, E. S. Rodionova, T. A. Malkina, K. A. Zykov, Zh. D. Bespalova, R. Sh. Bibilashvili, E. E. Efremov, S. P. Golitsyn | ||
| "... -холинорецепторов. Выявлена прямая корреляционная связь между частотой эпизодов желудочковой тахикардии и уровнями ..." | ||
| Vol 15, No 5 (2019) | Comparative Study of the Results of a Three-year Observation of Cardiologists and Surgeons in Patients with Peripheral Atherosclerosis | Abstract similar documents |
| L. S. Barbarash, A. N. Sumin, Yu. D. Medvedeva, E. V. Korok | ||
| "... group were older than these in the first group (p<0.001). Patients of the group 1 compared to the group ..." | ||
| Vol 9, No 1 (2013) | FACTORS EFFECTING THE DECOMPENSATION OF CHRONIC HEART FAILURE IN THE ELDERLY | Abstract PDF (Eng) similar documents |
| V. N. Larina, B. Ya. Bart, E. A. Vartanyan | ||
| "... (p<0.001), they were more often diagnosed with left ventricular aneurysm (p=0.001), chronic kidney ..." | ||
| Vol 21, No 1 (2025) | The no-reflow phenomenon: current treatment and prevention strategies | Abstract similar documents |
| S. V. Dil, E. V. Vyshlov, M. A. Kercheva, L. N. Maslov, V. V. Ryabov | ||
| "... coronary intervention (PCI). This condition, characterized by inadequate microcirculation following ..." | ||
| Vol 13, No 4 (2017) | COMPARATIVE ANALYSIS OF THE EFFICACY OF FIXED-DOSE COMBINATIONS OF AMLODIPINE/LISINOPRIL AND BISOPROLOL/HYDROCHLORTHIAZIDE IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION COMBINED WITH OBESITY AND OVERWEIGHT | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, M. V. Lopukhina | ||
| "... ) variability at night (p<0.05) and a morning surge in SBP (p<0.01), end systolic volume (p<0.05), systolic ..." | ||
| Vol 16, No 2 (2020) | Risk Factors, Clinical Features of the Course of Myocardial Infarction and Treatment of Young Patients Based on Two Hospital Registries | Abstract similar documents |
| O. L. Barbarash, D. Yu. Sedykh, I. S. Bykova, V. V. Kashtalap, A. D. Erlich | ||
| "... with myocardial infarction (MI) according to RECORD-3 are more often male smokers (p=0.001) with a heredity ..." | ||
| Vol 5, No 5 (2009) | EFFECT OF MITRAL REGURGITATION ON CHRONIC HEART FAILURE COURSE AND STRUCTURE-FUNCTIONAL HEART STATE | Abstract PDF (Eng) similar documents |
| V. N. Larina, B. Y. Bart, M. P. Mikhaylusova, B. N. Mamtsev | ||
| "... -diastolic dimension (p<0,001), end-systolic dimension (p<0,001), left atrium (p=0,004), end-diastolic vol ..." | ||
| Vol 9, No 4 (2013) | EFFECT OF IRON AND SELENIUM DRUGS ON DIASTOLIC MYOCARDIAL FUNCTION IN PATIENTS WITH ANEMIC CARDIOMYOPATHY | Abstract similar documents |
| E. V. Goncharova, A. V. Govorin | ||
| "... with cardiomyopathy. Flow rate rapid filling re- duced by 27.1% compared with this in control (p<0.001), and flow rate ..." | ||
| Vol 7, No 3 (2011) | EFFICACY AND TOLERABILITY OF LERCANIDIPINE IN ELDERLY PATIENTS WITH MILD TO MODERATE HYPERTENSION IN A PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY | similar documents |
| M. A. Ninci, R. Magliocca, A. Malliani | ||
| "... 24 ч и не сопровождается рефлекторной тахикардией. Препарат хорошо переносится и, учитывая его ..." | ||
| Vol 16, No 2 (2020) | Cardiomyopathy with Restrictive-Hypertrophic Phenotype and Initial Morphological Diagnosis “Amyloidosis” as a Manifestation of Danon Disease in a Woman | Abstract PDF (Eng) similar documents |
| O. V. Blagova, E. A. Kogan, V. P. Sedov, Yu. A. Lutokhina, A. V. Nedostup, A. V. Ott, L. M. Dashinemaeva, E. V. Zaklyazminskaya | ||
| "... неустойчивой желудочковой тахикардии и высокого расчетного риска внезапной смерти имплантирован кардиовертер ..." | ||
| Vol 17, No 6 (2021) | Drug-Induced Atrial Fibrillation / Atrial Flutter | Abstract similar documents |
| O. D Ostroumova, M. S. Chernyaeva, A. I. Kochetkov, A. E. Vorobieva, D. I. Bakhteeva, S. P. Korchagina, O. V. Bondarets, N. D. Boyko, D. A. Sychev | ||
| "... тахикардии и их влиянием на параметры центральной гемодинамики. Для диагностики необходимо проведение ..." | ||
| Vol 20, No 6 (2024) | The impact of clinical decision support systems on adherence to clinical guidelines and achieving target levels of low-density lipoprotein cholesterol in patients at risk of developing cardiovascular events (SuccESS) | Abstract similar documents |
| K. S. Astrakova (Benimetskaya), I. L. Mikheenko, A. E. Uranov, A. A. Gartung, E. A. Kovalev, A. A. Spiridonov, I. I. Shestova, I. L. Strokolskaya, M. A. Meshkova, L. I. Esev, А. V. Reznik, V. А. Petrakovskaia, A. M. Shangina, Yu. E. Efremova, I. V. Sergienko, M. V. Ezhov, O. L. Barbarash, P. N. Paleev | ||
| "... : +52.3%, p<0.001) in the main cohort and from 12.3% to 19.8% (+61.7%, p<0.001) in the additional cohort ..." | ||
| Vol 8, No 4 (2012) | COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I) | Abstract similar documents |
| S. Y. Martsevich, S. N. Tolpygina | ||
| "... .8±8.4 and -30.4±12.8/18.7±8 mm Hg for groups 1 and 2, respectively , p<0.001 for the both groups ..." | ||
| Vol 12, No 6 (2016) | EFFECT OF ANTIVIRAL THERAPY ON CARDIOHEMODYNAMIC INDICATORS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, E. V. Radaeva | ||
| "... myocardial mass (from 170 [225.5;213.5] to 159 [146;167] g; p<0.001), and size of the left atrium (LA; from ..." | ||
| Vol 10, No 3 (2014) | EFFECT OF ANTIVIRAL THERAPY ON HEART AND LIVER HEMODYNAMICS IN PATIENTS WITH VIRAL CIRRHOSIS | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, E. V. Radaeva | ||
| "... <0.001) were revealed. The right ventricle increased in size with the impairment of its diastolic ..." | ||
| Vol 9, No 6 (2013) | COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY | Abstract similar documents |
| I. V. Zhirov, G. K. Sarbalinova, S. N. Tereschenko | ||
| "... of the treatments was also assessed. Results. Group 1: the average CHF class (NYHA) decreased by 20.7% (p<0.01), EF ..." | ||
| Vol 12, No 6 (2016) | Cardiopulmonary factors associated with atrial fibrillation in patients with chronic obstructive pulmonary disease | Abstract PDF (Eng) similar documents |
| E. I. Leonova, G. G. Shechyan, V. S. Zadionchenko, T. V. Adasheva, A. D. Deev, I. V. Fedorova | ||
| "... .356; p=0.011), CRP level (R=0.442; p=0.001), the sizes of both atria (p<0.001), isovolumic relaxation ..." | ||
| Vol 12, No 1 (2016) | Cardiopulmonary factors associated with atrial fibrillation in patients with chronic obstructive pulmonary disease | Abstract PDF (Eng) similar documents |
| E. I. Leonova, G. G. Shechyan, V. S. Zadionchenko, T. V. Adasheva, A. D. Deev, I. V. Fedorova | ||
| "... .356; p=0.011), CRP level (R=0.442; p=0.001), the sizes of both atria (p<0.001), isovolumic relaxation ..." | ||
| Vol 7, No 5 (2011) | EFFECT OF ERYTHROPOIETIN ON THE CLINICAL COURSE OF CHRONIC HEART FAILURE IN PATIENTS WITH ANEMIA: RESULTS OF NOT COMPARATIVE STUDY | Abstract similar documents |
| V. M. Provotorov, S. A. Avdeeva | ||
| "... increase in hemoglobin (+12.5%; p<0.001) and hematocrit (+5.8%; p<0.001) levels, as well as increase in red ..." | ||
| Vol 2, No 1 (2006) | ANTIHYPERTENSIVE TREATMENT WITH COMBINED DRUG OF LOSARTAN AND HYDROCHLOROTHIAZIDE | Abstract similar documents |
| R. M. Linchak, K. M. Shumilova, A. D. Martinyuk, T. A. Gusaim, E. V. Semyonova, L. G. Zhirova, S. A. Boitsov | ||
| "... in 24 hrs. (from 141.9±1.9 to 128.6±0.8 mmHg, p<0.001), in daytime (from 146.8±2.6 to 135.8±1.0 mmHg, p ..." | ||
| Vol 15, No 6 (2019) | Possibilities of PRECISE-DAPT Score for Risk Prediction of Ischemic and Hemorrhagic Events in ST-Elevated Myocardial Infarction (According to the Data of the Registry Study in Kemerovo) | Abstract similar documents |
| D. Yu. Sedykh, V. V. Kashtalap, R. M. Velieva, O. L. Barbarash | ||
| "... disease and polyvascular disease (р=0.002), prior angina pectoris (р=0.001), as well as the course ..." | ||
| Vol 15, No 3 (2019) | Disorders of the Cardiovascular System in Patients with Chronic Viral Hepatitis | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko | ||
| "... valve in patients of groups 1 and 2 was lower than in the control by 15% and 17%, respectively (p<0.001 ..." | ||
| Vol 19, No 2 (2023) | Clinical Efficacy and Safety of Empagliflozin in Patients with Acute Heart Failure from the First Day of Hospitalization | Abstract similar documents |
| D. P. Golubovskaya, V. N. Karetnikova, A. B. Osokina, I. P. Oleinik, O. L. Barbarash | ||
| "... , only in the main group there was an improvement in all clinical indicators (p<0.01), an increase ..." | ||
| Vol 14, No 2 (2018) | SINGLE AND MULTIPLE ISCHEMIC BRAIN MICROLESIONS AFTER CAROTID ARTERY STENTING | Abstract similar documents |
| E. S. Bulgakova, T. V. Tvorogova, В. A. Rudenko, O. М. Drapkina | ||
| "... patients (n=84) microlesion count correlated with age (γ=0.243; p<0.01), preprocedural hemoglobin level (γ ..." | ||
| Vol 18, No 4 (2022) | Safety and Tolerability of Implanted Subcutaneous Cardioverter-Defibrillator Systems | Abstract similar documents |
| A. V. Vereshchagina, T. M. Uskach, O. V. Sapelnikov, V. A. Amanatova, I. R. Grishin, A. A. Kulikov, V. S. Kostin, R. S. Akchurin | ||
| "... тахикардией (ЖТ), необходимостью в антибрадикардитической или ресинхронизирующей терапии]; больные с шириной ..." | ||
| Vol 7, No 2 (2011) | EFFICACY AND SAFETY OF BISOPROLOL IN YOUNG MEN WITH ARTERIAL HYPERTENSION AND OBESITY | Abstract similar documents |
| A. G. Avtandilov, I. I. Esenova, S. L. Petrosov | ||
| "... мощность спектра достоверно выросла. Уменьшилась исходная тахикардия. В результате 12 нед терапии ..." | ||
| Vol 18, No 4 (2022) | Detection and Treatment of Hyperuricemia in Clinical Practice (According to the PROFILE Outpatient Registry) | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, A. V. Zagrebelnyy, Yu. V. Lukina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, S. V. Blagodatskikh, I. V. Budaeva, E. S. Nekoshnova, O. M. Drapkina | ||
| "... with the frequency of UA control (p<0.001). In patients with AH, an increase in the level of sUA was detected ..." | ||
| Vol 19, No 1 (2023) | Associations of Arterial Stiffness and Bone Mineral Density in Postmenopausal Women | Abstract similar documents |
| O. Yu. Isaykina, I. A. Skripnikova, M. A. Kolchina, O. V. Kosmatova, V. E. Novikov, T. T. Tsoriev | ||
| "... (rs=0.12, p<0.05); a more pronounced negative correlation was obtained for BMD (rs=0.16, p<0.01 ..." | ||
| Vol 6, No 1 (2010) | ANTIHYPERTENSIVE EFFICACY OF VALSARTAN IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION: THE FIRST RESULTS OF RUSSIAN MULTICENTER OPEN STUDY | Abstract similar documents |
| V. I. Podzolkov, V. A. Bulatov, A. V. Vigdorchik | ||
| "... . SBP decreased by 37,5 mm Hg (р<0,01) in smoking patients and by 37,6 mm Hg (р<0,01) in non-smoking ..." | ||
| Vol 6, No 1 (2010) | ACTOVEGIN INFLUENCE ON METABOLIC AND VASOMOTOR FUNCTION OF MICROVASCULAR ENDOTHELIAL OF HUMAN SKIN | Abstract similar documents |
| A. A. Fedorovich, A. N. Rogoza, E. M. Kanisheva, S. A. Boytsov | ||
| "... increased in maximal amplitude endothelial rhythm (at a frequency of 0.01 Hz) by 76% (p<0,001 ..." | ||
| Vol 6, No 2 (2010) | EFFICACY AND SAFETY OF CONTROLLED RELEASE METOPROLOL TARTRATE IN PATIENTS WITH ARTERIAL HYPERTENSION: ERA STUDY RESULTS | Abstract similar documents |
| O. L. Barbarash, M. V. Zykov | ||
| "... systolic and diastоlic BP was reduced by 36 and 17 mmHg respectively (р0,em001/em for both), and target BP ..." | ||
| Vol 6, No 4 (2010) | EFFICACY OF VARIOUS DRUG FORMS OF LYCOPENE IN PATIENTS WITH DYSLIPIDEMIA | Abstract similar documents |
| P. Ya. Dovgalevsky, V. A. Klochkov, N. E. Chalyk, O. M. Ansimova, I. Petyaev | ||
| "... application led to significant reduction in levels of TC (from 247.1±27 to 186.5±12 mg/dl; p0.em001/em), LDC (from ..." | ||
| Vol 7, No 6 (2011) | EFFECT OF METOPROLOL THERAPY ON THE ARTERIAL STIFFNESS | Abstract similar documents |
| V. E. Oleynikov, I. B. Matrosova, Y. A. Tomashevskaya, L. I. Gusakovskaya, E. A. Melnikova | ||
| "... Hg; p0.em001/em; dyastolic BP decreased from 90 (87;93) to 80 (77;84) mm Hg; p0.em001/em ..." | ||
| Vol 6, No 5 (2010) | INTERRELATION BETWEEN PERSISTENT NECROSIS OF CARDIOMYOCYTES AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE | Abstract PDF (Eng) similar documents |
| E. N. Golovenko, D. A. Napalkov, V. A. Sulimov | ||
| "... (FC) III-IV than in those with CHF of FC I-II (p0.em001/em). Negative correlation was revealed between TrI ..." | ||
| Vol 7, No 6 (2011) | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC SIMVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA | Abstract similar documents |
| V. P. Voronina, S. N. Tolpygina, N. P. Kutishenko, N. A. Dmitrieva, Yu. V. Lukina, S. Yu. Martsevich | ||
| "... simvastatin TC decreased from 6.4±0.8 to 4.4±0.6 mmol/l (p0.em001/em) and from 6.0±0.7 to 4.1±0.7 mmol/l (p0.em001/em ..." | ||
| Vol 16, No 4 (2020) | Real-Life International Normalized Ratio Profile in Patients with Non-Valvular Atrial Fibrillation Prescribed Vitamin K Antagonist | Abstract PDF (Eng) similar documents |
| S. I. Farag, O. S. Arafa, A.A. E. Hassan, H. M. Mashhour, A. M. Bendary | ||
| "... (TTR≥65%) were younger (p0.em001/em), more often men (p0.074) with a high level of education (p0.em001/em ..." | ||
| Vol 8, No 2 (2012) | SHIFTWORK AS ONE OF RISK FACTORS OF ARTERIAL HYPERTENSION AND METABOLIC DISORDERS | Abstract similar documents |
| I. S. Dzherieva, N. I. Volkova, S. I. Rapoport | ||
| "... higher than that in employees with steady work schedule (34.4 vs 27.4%, respectively; рem0.01/em ..." | ||
| Vol 14, No 5 (2018) | Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome | Abstract PDF (Eng) similar documents |
| Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal | ||
| "... , triglyceride (p0.em001/em) and significant increase in high-density lipoprotein cholesterol (p0.em001/em) when compared ..." | ||
| Vol 16, No 5 (2020) | Atrial Fibrillation: the Association with Physical Activity and the Effects of Cardiac Rehabilitation | Abstract similar documents |
| M. G. Bubnova, D. M. Aronov | ||
| "... of physical training in patients with AF after RFA: increase in exercise duration by 18.6% (p0.em001/em) and load ..." | ||
| Vol 18, No 1 (2022) | Omega-3 Polyunsaturated Fatty Acids: the Role in Prevention of Atrial Fibrillation in Patients with Coronary Artery Disease after Coronary Artery Bypass Graft Surgery | Abstract PDF (Eng) similar documents |
| O. A. Rubanenko, Yu. V. Shchukin, L. V. Limareva, T. K. Ryazanova, A. O. Rubanenko, I. L. Davydkin | ||
| "... was 39.3% higher (p=0.em001/em), interleukin-10 – 20.2% higher (p=em0.01/em), superoxide dismutase – 78.9% higher ..." | ||
| Vol 15, No 1 (2019) | Prognostic Value of ECG in Patients with Pulmonary Embolism | Abstract similar documents |
| I. S. Mullova, T. V. Pavlova, S. M. Khokhlunov, D. V. Duplyakov | ||
| "... -complete right bundle branch block (RBBB) (16.3 vs 37.9%; p=0.em001/em), ST segment elevation in lead III (9 ..." | ||
| Vol 15, No 2 (2019) | Remodeling of the Pulmonary Circulation in Patients with Viral Liver Cirrhosis | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko | ||
| "... - 0.9 [0.8;1.31 ], in the 2nd group - 0.8 [0.78; 1.2] with a control value of 1.6 [1.2;1.94] (p0.em001/em ..." | ||
| Vol 17, No 6 (2021) | Patients with a Combination of Atrial Fibrillation and Chronic Heart Failure in Clinical Practice: Comorbidities, Drug Treatment and Outcomes | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. Yu. Martsevich, Yu. V. Mareev, S. S. Yakushin, E. Yu. Andreenko, A. N. Vorobiev, K. G. Pereverzeva, A. V. Zagrebelny, E. Yu. Okshina, V. V. Yakusevich, Vl. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, A. N. Makoveeva, Yu. E. Tatsiy, S. A. Boytsov, O. M. Drapkina | ||
| "... a higher risk of thromboembolic complications (CHA2DS2-VASc – 4.68±1.59 and 3.10±1.50; p0.em001/em ..." | ||
| Vol 6, No 4 (2010) | COMPARISON OF CLINICAL EFFICACY OF ORIGINAL BISOPROLOL AND ITS GENERIC DRUG IN PATIENTS WITH STABLE ANGINA AND CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Abstract similar documents |
| N. Yu. Grigorieva, E. G. Sharabrin, A. N. Kuznetsov | ||
| "... reduction from 98.6±2.5 to 58.6±3.5 bt/min (р0.em001/em) was found with the 24 hour electrocardiogram-monitoring ..." | ||
| Vol 13, No 5 (2017) | COMORBIDITIES IN PATIENTS WITH ISCHEMIC HEART DISEASE: GENDER DIFFERENCES | Abstract similar documents |
| A. N. Sumin, E. V. Korok, A. V. Shcheglova, O. L. Barbarash | ||
| "... and more often had excess body weight (p0.em001/em). The majority of current smokers were males (p0.em001/em ..." | ||
| Vol 14, No 1 (2018) | STUDY OF CLINICAL EFFICACY OF ORIGINAL AND GENERIC DRUGS OF IVABRADINE IN PATIENTS WITH STABLE ANGINA (СOMPARATIVE STUDY) | Abstract similar documents |
| S. V. Povetkin, Ju. V. Luneva | ||
| "... 83.0±6.18 to 67.6±5.97 beats/min in the 2nd group, pem0.01/em for both) and in blood pressure level ..." | ||
| Vol 11, No 3 (2015) | THE EFFECT OF NEBIVOLOL ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH MILD HYPERTENSION | Abstract similar documents |
| I. L. Tepoyan, D. V. Nebieridze, I. A. Skripnikova, A. S. Safaryan, V. A. Vygodin, V. E. Novikov, L. M. Murashko | ||
| "... increase in BMD in the spine according to the T-test from -1.7±0.4 SD to -1.4±0.53 SD (p0.em001/em), while ..." | ||
| Vol 14, No 2 (2018) | MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION | Abstract similar documents |
| L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov | ||
| "... density cholesterol (LDC) by 52.4% (p0.em001/em) was found after 24 weeks in Group 1. Achieving the target LDC ..." | ||
| Vol 18, No 5 (2022) | Clinical and Anamnestic Characteristics, Cardiovascular Pharmacotherapy and Long-term Outcomes in Multimorbid Patients after COVID-19 | Abstract similar documents |
| A. A. Smirnov, M. M. Loukianov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Maltseva, E. N. Belova, V. G. Klyashtorniy, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina | ||
| "... . The age of post-COVID patients with CVMM was 73.7±9.6 years, without CVD – 49.4±12.4 years (p0.em001/em ..." | ||
| 1 - 100 of 341 Items | 1 2 3 4 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
.jpg)
